| Literature DB >> 29382726 |
Linlin Zhao1, Xinbo Wang1, Yue Yu1, Lu Deng2, Lei Chen2, Xiaoping Peng2, Chenchen Jiao2, Guoli Gao3, Xiao Tan2, Weijuan Pan1, Xin Ge4, Ping Wang5.
Abstract
Mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) integrates various environmental signals to regulate cell growth and metabolism. DEPTOR, also termed DEPDC6, is an endogenous inhibitor of mTORC1 and mTORC2 activities. The abundance of DEPTOR centrally orchestrates the mTOR signaling network. However, the mechanisms by which DEPTOR stability is regulated are still elusive. Here, we report that OTU domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) specifically deubiquitinates DEPTOR in a deubiquitination assay. We found that OTUB1 directly interacted with DEPTOR via its N-terminal domain, deubiquitinated DEPTOR, and thereby stabilized DEPTOR in a Cys-91-independent but Asp-88-dependent manner, suggesting that OTUB1 targets DEPTOR for deubiquitination via a deubiquitinase activity-independent non-canonical mechanism. The interaction between OTUB1 and DEPTOR was enhanced when the cells were treated with amino acids. Moreover, OTUB1 suppressed amino acid-induced activation of mTORC1 in a DEPTOR-dependent manner and thereby ultimately controlled cellular autophagy, cell proliferation, and size. Our findings reveal a mechanism that stabilizes the mTORC1 inhibitor DEPTOR via OTUB1's deubiquitinase activity. Our insights may inform research into various mTOR activity-related diseases, such as cancer, and may contribute to the identification of new diagnostic markers and therapeutic strategies for cancer treatments.Entities:
Keywords: DEPTOR; OTU domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1); cancer biology; cell signaling; deubiquitylation (deubiquitination); mTORC1; protein stability; tumor cell biology
Mesh:
Substances:
Year: 2018 PMID: 29382726 PMCID: PMC5880136 DOI: 10.1074/jbc.M117.809533
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157